Figure 2 illustrates the remission rates by GH nadir <1 ng/mL in patients treated with SRS or FSRT, while Figure 3 depicts the longitudinal progression of hypopituitarism by axis in patients following SRS and FSRT. Here, GH1 is linked to hypopituitarism.